# Somatostatin in Living Donor Liver Transplantation

> **NCT04107428** · PHASE4 · UNKNOWN · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 56 (estimated)

## Conditions studied

- End Stage Liver DIsease
- Portal Hypertension

## Interventions

- **DRUG:** Somatostatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04107428
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12
- **Primary completion:** 2020-08
- **Final completion:** 2022-02
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2019-09-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04107428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04107428, "Somatostatin in Living Donor Liver Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04107428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*